Erik de Kort appointed as new Managing Director as of July 1, 2025

Focus Care Pharmaceuticals is pleased to announce a key leadership transition that
marks an exciting new phase in the company’s development. Effective July 1, 2025, Erik
de Kort will assume the role of Managing Director of Focus Care Pharmaceuticals.

Erik joined Focus Care in 2010 and has since held several strategic positions within the
company, most recently as Director Business Development & Pharmaceutical Affairs.

He brings to this new role over 15 years of experience in the pharmaceutical sector,
both in the Netherlands and internationally. Erik holds a Master’s degree in
Pharmaceutical Sciences and recently completed a Global Executive MBA.

“Erik has played an essential role in shaping Focus Care’s growth and strategic
direction,” said Maurits Haasnoot, current Managing Director and CEO of Focus Care.

“I’m proud to pass the baton to Erik. His leadership, expertise, and commitment to our
mission make him the ideal person to lead Focus Care Pharmaceuticals into the next
phase.”

Maurits Haasnoot will continue in his position as CEO and Owner of Focus Care,
focusing on the overarching strategy and long-term development of the organization.
This leadership transition is part of Focus Care’s broader strategy to expand its role in
the pharmaceutical and medical device supply chain, and to strengthen its
organizational structure to support sustainable growth.

The entire team at Focus Care congratulates Erik on his new role and looks forward to
continued collaboration under his leadership.